UK & Germany approve first human trials of #COVID19 vaccine

United Kingdom and Germany has approved the first human trials of a possible coronavirus vaccine.

Matt Hancock, United Kingdom health secretary, says from Thursday, there will be clinical trials of a potential COVID-19 vaccine on patients.

The vaccine, called ChAdOx1 nCoV-19, is being developed by scientists at the University of Oxford.

Speaking at the daily Downing Street press conference, Hancock said the government was “throwing everything” at the vaccine drive.

He announced a provision of £20 million had been made for the Oxford team to help fund the clinical trials.

Hancock said an additional £22.5 million in funding will be made available for researchers at Imperial College, London.

He said the government will “back them to the hilt and give them every resource they need to get them the best possible chance of success as soon as possible”.

“In the long run the best way to defeat coronavirus is through a vaccine. This is a new disease, this is uncertain science, but I’m certain that we will throw everything we’ve got at developing a vaccine,” he said.

“The UK is at the forefront of the global effort. We’ve put more money than any other country into the global search for a vaccine. And for all the efforts around the world, two of the leading vaccine developments are taking place here at home, at Oxford and Imperial.

“Both of these promising projects are making rapid progress and I’ve told the scientists leading them that we’ll do everything we can to support them.

“And today making available 20 million pounds to the oxford team to fund their clinical trials. The team has accelerated its process working, with the regulator of the MHRA ((Medicines and Healthcare Regulatory Agency), who have been absolutely brilliant.

“As a result, I can announce that the vaccine from the oxford project will be trialled in people from this Thursday.

“In normal time, reaching this stage takes years and I am very proud of the work taken so far.

“At the same time, we will invest in manufacturing capability so that if either of these vaccines safely works then we can make it available for the British people as soon as humanly possible.”

The German Federal Institute for Vaccines also said Biontech, a Mainz-based company, made the potential vaccine for COVID-19.

The vaccine, named BNT162, was developed alongside Pfizer, another pharmaceutical company.

According to the institute, 200 healthy people between the ages of 18 and 55 will be administered doses of the drug at the initial stage of the trial, while the second phase will be administered on higher-risk individuals.

The clinical testing of BNT162 will also be done in the United States.

The World Health Organisation (WHO) said there are about 20 different potential COVID-19 vaccines currently in development.

The United Kingdom had announced that there would be clinical trials of a possible COVID-19 vaccine on patients from Thursday.

The vaccine, called ChAdOx1 nCoV-19, is being developed by scientists at the University of Oxford.

According to Worldometers, the number of confirmed cases of COVID-19 has exceeded 2.5 million globally, with over 178,000 deaths. But over 701,000 patients have recovered from the disease.

Leave a Reply